UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy

Nature communications, 2017-06, Vol.8 (1), p.15507-15507, Article 15507

2017

Volltextzugriff (PDF)

The interplay between membrane topology and mechanical forces in regulating T cell receptor activity

Communications biology, 2022-01, Vol.5 (1), p.40-16, Article 40

2022

Volltextzugriff (PDF)

A genome-wide association study identifies a novel susceptibility locus for the immunogenicity of polyethylene glycol

Nature communications, 2017-09, Vol.8 (1), p.522-7, Article 522

2017

Volltextzugriff (PDF)

Effect of Cellular Location of Human Carboxylesterase 2 on CPT-11 Hydrolysis and Anticancer Activity

PloS one, 2015-10, Vol.10 (10), p.e0141088-e0141088

2015

Volltextzugriff (PDF)

Reversible glycosidic switch for secure delivery of molecular nanocargos

Nature communications, 2018-05, Vol.9 (1), p.1843-13, Article 1843

2018

Volltextzugriff (PDF)

Disruption of Scube2 Impairs Endochondral Bone Formation

Journal of bone and mineral research, 2015-07, Vol.30 (7), p.1255-1267

2015

Volltextzugriff (PDF)

High-Affinity Ligands Can Trigger T Cell Receptor Signaling Without CD45 Segregation

Frontiers in immunology, 2018-04, Vol.9, p.713-713

2018

Volltextzugriff (PDF)

Premature Drug Release from Polyethylene Glycol (PEG)-Coated Liposomal Doxorubicin via Formation of the Membrane Attack Complex

ACS nano, 2020-07, Vol.14 (7), p.7808-7822

2020

Volltextzugriff (PDF)

Entropy-driven binding of gut bacterial β-glucuronidase inhibitors ameliorates irinotecan-induced toxicity

Communications biology, 2021-03, Vol.4 (1), p.280-10, Article 280

2021

Volltextzugriff (PDF)

High-throughput sorting of the highest producing cell via a transiently protein-anchored system

PloS one, 2014-07, Vol.9 (7), p.e102569-e102569

2014

Volltextzugriff (PDF)

Impediments to enhancement of CPT-11 anticancer activity by E. coli directed beta-glucuronidase therapy

PloS one, 2015-02, Vol.10 (2), p.e0118028

2015

Volltextzugriff (PDF)

Antibodies against Poly(ethylene glycol) Activate Innate Immune Cells and Induce Hypersensitivity Reactions to PEGylated Nanomedicines

ACS nano, 2023-03, Vol.17 (6), p.5757-5772

2023

Volltextzugriff (PDF)

The B7-1 cytoplasmic tail enhances intracellular transport and mammalian cell surface display of chimeric proteins in the absence of a linear ER export motif

PloS one, 2013-09, Vol.8 (9), p.e75084-e75084

2013

Volltextzugriff (PDF)

Antiangiogenesis Targeting Tumor Microenvironment Synergizes Glucuronide Prodrug Antitumor Activity

Clinical cancer research, 2009-07, Vol.15 (14), p.4600-4611

2009

Volltextzugriff (PDF)

Prognosis of Non–Small Cell Lung Cancer Patients by Detecting Circulating Cancer Cells in the Peripheral Blood with Multiple Marker Genes

Clinical cancer research, 2005-01, Vol.11 (1), p.173-179

2005

Volltextzugriff (PDF)

Analytical Measurement of PEGylated Molecules

Bioconjugate chemistry, 2012-05, Vol.23 (5), p.881-899

2012

Volltextzugriff (PDF)

Bispecific T-cell engagers non-covalently decorated drug-loaded PEGylated nanocarriers for cancer immunochemotherapy

Journal of controlled release, 2022-04, Vol.344, p.235-248

2022

Volltextzugriff (PDF)

Local enzymatic hydrolysis of an endogenously generated metabolite can enhance CPT-11 anticancer efficacy

Molecular cancer therapeutics, 2009-04, Vol.8 (4), p.940-946

2009

Volltextzugriff (PDF)

Engineering stable and non-immunogenic immunoenzymes for cancer therapy via in situ generated prodrugs

Journal of controlled release, 2024-05, Vol.369, p.179-198

2024

Volltextzugriff (PDF)

Discovery of Specific Inhibitors for Intestinal E. coli β-Glucuronidase through In Silico Virtual Screening

TheScientificWorld, 2015, Vol.2015 (2015), p.1-8

2015

Volltextzugriff (PDF)

Cutting Edge: mechanical forces acting on T cells immobilized via the TCR complex can trigger TCR signaling

The Journal of immunology (1950), 2010-06, Vol.184 (11), p.5959-5963

2010

Volltextzugriff (PDF)

A recombinant scFv-FasLext as a targeting cytotoxic agent against human Jurkat-Ras cancer

Journal of biomedical science, 2013-03, Vol.20 (1), p.16-16, Article 16

2013

Volltextzugriff (PDF)

Bispecific antibody (HER2 × mPEG) enhances anti-cancer effects by precise targeting and accumulation of mPEGylated liposomes

Acta biomaterialia, 2020-07, Vol.111, p.386-397

2020

Volltextzugriff (PDF)

One-step mixing with humanized anti-mPEG bispecific antibody enhances tumor accumulation and therapeutic efficacy of mPEGylated nanoparticles

Biomaterials, 2014-12, Vol.35 (37), p.9930-9940

2014

Volltextzugriff (PDF)

Engineering Chimeric Receptors To Investigate the Size- and Rigidity-Dependent Interaction of PEGylated Nanoparticles with Cells

ACS nano, 2016-01, Vol.10 (1), p.648-662

2016

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(70)

Sprache

Englisch
(70)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(67)
Animals
(53)
Life Sciences & Biomedicine
(51)
Mice
(45)
Female
(28)
Biological And Medical Sciences
(23)
Cell Line, Tumor
(21)
Oncology
(21)
Medical Sciences
(18)
Glucuronidase - Metabolism
(17)
Tumors
(16)
Mice, Inbred Balb C
(14)
Mice, Nude
(14)
Science & Technology - Other Topics
(13)
Pharmacology. Drug Treatments
(12)
Antineoplastic Agents
(11)
Chemistry
(11)
Physical Sciences
(11)
Camptothecin - Analogs & Derivatives
(10)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy

The interplay between membrane topology and mechanical forces in regulating T cell receptor activity

A genome-wide association study identifies a novel susceptibility locus for the immunogenicity of polyethylene glycol

Effect of Cellular Location of Human Carboxylesterase 2 on CPT-11 Hydrolysis and Anticancer Activity

Reversible glycosidic switch for secure delivery of molecular nanocargos

Disruption of Scube2 Impairs Endochondral Bone Formation

High-Affinity Ligands Can Trigger T Cell Receptor Signaling Without CD45 Segregation

Premature Drug Release from Polyethylene Glycol (PEG)-Coated Liposomal Doxorubicin via Formation of the Membrane Attack Complex

Entropy-driven binding of gut bacterial β-glucuronidase inhibitors ameliorates irinotecan-induced toxicity

High-throughput sorting of the highest producing cell via a transiently protein-anchored system

Impediments to enhancement of CPT-11 anticancer activity by E. coli directed beta-glucuronidase therapy

Antibodies against Poly(ethylene glycol) Activate Innate Immune Cells and Induce Hypersensitivity Reactions to PEGylated Nanomedicines

The B7-1 cytoplasmic tail enhances intracellular transport and mammalian cell surface display of chimeric proteins in the absence of a linear ER export motif

Antiangiogenesis Targeting Tumor Microenvironment Synergizes Glucuronide Prodrug Antitumor Activity

Prognosis of Non–Small Cell Lung Cancer Patients by Detecting Circulating Cancer Cells in the Peripheral Blood with Multiple Marker Genes

Analytical Measurement of PEGylated Molecules

Bispecific T-cell engagers non-covalently decorated drug-loaded PEGylated nanocarriers for cancer immunochemotherapy

Local enzymatic hydrolysis of an endogenously generated metabolite can enhance CPT-11 anticancer efficacy

Engineering stable and non-immunogenic immunoenzymes for cancer therapy via in situ generated prodrugs

Discovery of Specific Inhibitors for Intestinal E. coli β-Glucuronidase through In Silico Virtual Screening

Cutting Edge: mechanical forces acting on T cells immobilized via the TCR complex can trigger TCR signaling

A recombinant scFv-FasLext as a targeting cytotoxic agent against human Jurkat-Ras cancer

Bispecific antibody (HER2 × mPEG) enhances anti-cancer effects by precise targeting and accumulation of mPEGylated liposomes

One-step mixing with humanized anti-mPEG bispecific antibody enhances tumor accumulation and therapeutic efficacy of mPEGylated nanoparticles

Engineering Chimeric Receptors To Investigate the Size- and Rigidity-Dependent Interaction of PEGylated Nanoparticles with Cells

Aktive Filter

Suchergebnisse filtern